AIDSmeds Founder Peter Staley interviewed Dr. Martin Markowitz of the Aaron Diamond AIDS Research Center and one of the investigators who announced very promising results about MK-0518, Merck's new integrase inhibitor, the first in a completely new class of anti-HIV drugs.

Click here to listen to the 5 minute interview.
(5.0 MB mp3 file)